Delfi Diagnostics, Inc.
Biotechnology
Delfi Diagnostics is a biotechnology company specializing in the development of advanced blood test systems for early cancer detection. Its innovative technology uses machine learning to analyze blood and genome samples, identifying cancer-associated DNA fragments.
Founded: 2019
Susan Tousi Chief Executive Officer |
Victor Velculescu Co-Founder & Board Member |
Jennifer Buechel Chief Operating Officer & President |
Doug Schenkel Chief Financial Officer & Head of Strategy |
Nicholas Dracopoli Co-Founder & Chief Scientific Officer |
Jessica Meng Chief Commercial Officer |
Alessandro Leal Co-Founder & Medical Director of Translational Research |
Robert Scharpf Co-Founder & Head of Computational Biology |
Peter Bach Chief Medical Officer |